Mavinwood PLC
25 May 2006
25 May 2006
Mavinwood plc ('the Company')
Additional Listing
Application has been made for 9,772,795 ordinary shares of 0.1p each in the
Company ('Ordinary Shares') to be admitted to trading on the AIM market of the
London Stock Exchange ('AIM').
The new Ordinary Shares represent 50 per cent. of the total deferred
consideration of £2,150,015 being paid by the Company pursuant to a sale and
purchase agreement dated 13 April 2005 under which the Company agreed to
purchase the entire issued share capital of Restore Group Holdings Limited.
4,642,658 of the new Ordinary Shares are being issued to John Minton, a director
of the Company, who will as a result hold 4,762,658 Ordinary Shares
representing 1.4 per cent. of the enlarged issued share capital of the Company.
These shares rank pari passu with the Company's existing Ordinary Shares and
dealings are expected to commence on 31 May 2006 on AIM.
Contacts:
Kevin Mahoney / Mike Vincent
Mavinwood plc
020 7661 9650
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.